What is T Cell Lymphoma?
T-cell lymphoma (TCL) is a rare disease in which T lymphocytes in the lymphoid system (a type of white blood cell that helps the body fight infections) become malignant. TCLs account for about one in ten cases of non-Hodgkin lymphoma.
Hepatosplenic T-Cell Lymphoma (HSTCL), the cancer that took the life of our founder, Ben Cushing, is a very rare, aggressive lymphoma that develops in the liver, spleen, and bone marrow. It primarily affects young adults and is more prevalent in men than women. Sadly, at this time, there is no known cure and once diagnosed, it progresses very rapidly.
At the Cush It to The Limit organization, we hope to change that prognosis. Research is essential to understanding the HSTCL targets and progression so that new treatment options can be found. But sadly, research targeted to any T-Cell Lymphoma is sparse. That is why our work at Cush it to the Limit is so critical. We believe that every discovery by our researchers contributes to the overall body of knowledge that will lead to improved treatment options for all TCLs.
Links to other organizations focused on T-Cell Lymphoma
We are grateful to the following organizations for their ongoing commitment to research, awareness and education on TCLs.
The T-Cell Leukemia Lymphoma Foundation is a non-profit organization focused on: 1) providing education about these rare cancers to patients and family members; 2) assisting patients with treatment-related expenses through charitable funding; 3) allocating charitable funds to support such scientific research. Extensive research is vital to learning and understanding more about T-cell leukemias and lymphomas.